Ursprung des Netzwerks ersten Grades von Lars Danielsson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Lund University Bioscience AB
 Lund University Bioscience AB Investment ManagersFinance Lund University Bioscience AB (LU Bio) is an investment firm located in Lund, Sweden. In May 2007, LU Bio was founded by the parent firm, Lund University Development AB. They specialize in early-stage investments within the life sciences segment. Lund University was founded by the Swedish government in 1666. The university has three main research areas: medicine and pharmaceuticals, globally sustainable societal development, and the life sciences.
3
| Extinct | Investment Managers | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lars Danielsson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Lund | College/University | Doctorate Degree Undergraduate Degree | |
WC Likvid AB
 WC Likvid AB Real Estate DevelopmentFinance WC Likvid AB owns and manages movable and immovable property. The company was founded by Tadeusz Wojciech Wieloch on June 5, 2009 and is headquartered in Staffanstorp, Sweden. | Real Estate Development | President Chairman | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Corporate Officer/Principal | |
Rechon Life Science AB
 Rechon Life Science AB Pharmaceuticals: MajorHealth Technology Rechon Life Science AB manufactures medicines. It specializes in aseptic injectables and sprays for nasal and oral administration. The firm's products include Iron Sucrose Injection. The firm's services include formulation and analytical development, clinical trial, stability studies, and storage and distritutions. The company is headquartered in Limhamn, Sweden. | Pharmaceuticals: Major | Chief Administrative Officer | |
PolyPeptide Laboratories (Sweden) AB
 PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Biotechnology | Chief Administrative Officer | |
Ball Beverage Packaging Fosie AB
 Ball Beverage Packaging Fosie AB Miscellaneous ManufacturingProducer Manufacturing Part of Ball Corp., Ball Beverage Packaging Fosie AB is a Swedish company that manufactures consumer packaging products and solutions. The company is based in Malmö, Sweden. | Miscellaneous Manufacturing | Comptroller/Controller/Auditor | |
| PROBI AB | Biotechnology | Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director of Finance/CFO | |
| IDOGEN AB (PUBL) | Biotechnology | Director of Finance/CFO | |
| LIDDS AB | Pharmaceuticals: Major | Director of Finance/CFO | |
Merozyne Therapeutics AB
 Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Colzyx AB
 Colzyx AB Medical SpecialtiesHealth Technology Colzyx AB is a biotechnology company located in Lund, Sweden. The Swedish company specializes in wound care and have developed a new wound dressing called Woundcom. This innovative product not only accelerates wound healing but also has an antibacterial effect. The private company has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 947034. | Medical Specialties | Director/Board Member | |
Pain Drainer AB
 Pain Drainer AB Internet Software/ServicesTechnology Services Pain Drainer AB operates an artificial intelligence drug-free self-management tool for chronic pain patients. The private company is based in Stockholm, Sweden. Cecilia Ann-Christin Malmborg Hager has been the CEO of the Swedish company since 2019. | Internet Software/Services | Chief Executive Officer | |
| Nanoecho AB | Director/Board Member | ||
| Executive Foundation Lund | College/University | Chief Executive Officer | |
Xlmmune AB
 Xlmmune AB Pharmaceuticals: MajorHealth Technology Xlmmune AB is a Swedish pharmaceutical company that specializes in pharmaceutical preparation. The private company is based in Lund, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| Bulb Intelligence AB | Director/Board Member | ||
| Avena Partners AB | Director/Board Member | ||
| Hager Consulting AB | Director/Board Member | ||
Diaprost AB
 Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
| IMMUNOVIA AB | Pharmaceuticals: Major | Director/Board Member | |
| SENZAGEN AB | Biotechnology | Director/Board Member | |
| CANTARGIA AB | Pharmaceuticals: Major | Chief Executive Officer | |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| PHARMIVA AB (PUBL) | Miscellaneous Commercial Services | Director of Finance/CFO |
Statistik
International
| Schweden | 27 |
| Dänemark | 2 |
Sektoral
| Health Technology | 17 |
| Consumer Services | 3 |
| Commercial Services | 3 |
| Finance | 2 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 15 |
| Chief Executive Officer | 7 |
| Director of Finance/CFO | 5 |
| Corporate Officer/Principal | 2 |
| Chief Administrative Officer | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Anki Malmborg Hager | 19 |
| Per-Ola Forsberg | 11 |
| Eskil Söderlind | 3 |
- Börse
- Insiders
- Lars Danielsson
- Unternehmensverbindungen
